CardioNet, Inc. (BEAT) Reports Smaller Q4 Loss, Sales Miss
CardioNet, Inc. (NASDAQ: BEAT) reported Q4 EPS of ($0.04), $0.12 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $26.8 million versus the consensus estimate of $27.99 million.
For earnings history and earnings-related data on CardioNet, Inc. (BEAT) click here.
For earnings history and earnings-related data on CardioNet, Inc. (BEAT) click here.
